Company performance
Add to research
Current Price
as of Apr 17, 2025$79.51
P/E Ratio
38.45
Market Cap
$15.9B
Description
Add to research
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Metrics
Add to research
Overview
- HQSan Ramon, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerCOO
- Price$79.51+1.64%
Trading Information
- Market cap$15.90B
- Float99.35%
- Average Daily Volume (1m)2,110,970
- Average Daily Volume (3m)2,003,291
- EPS$2.08
Company
- Revenue$3.93B
- Rev growth (1yr)3.55%
- Net income$104.30M
- Gross margin63.29%
- EBITDA margin28.30%
- EBITDA$273.00M
- EVN/A
- EV/RevenueN/A
- P/E38.45
- P/S4.07
- P/B1.96
- Debt/Equity31.25
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account